Daily - Wednesday 27 August 2008
Equateq bullish about lipid API market
A facility operated by fatty acid specialist Equateq on the island of Lewis in Scotland has met with UK good manufacturing practice (GMP) standards for the production of lipid-based APIs for the drug industry.
FDA warns Sandoz on unvalidated manufacturingThe FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina. |
Second Daytrana recall as liner problems continueShire and Noven have voluntarily withdrawn batches of the ADHD drug Daytrana for the second time in 12 months due to ongoing problems with the product’s release liner. |
Pharmaceutical manufacturing: people on the movein-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector. |
Funding imminent for versatile drug delivery techNanoBio is believed to be on the verge of securing funding to continue developing its NanoStat drug delivery platform. |
Today's headlines across the Pharmaceutical industry
Galapagos adds Sareum services to BioFocus portfolioGalapagos has bolstered the portfolio of its BioFocus DPI contract services unit by purchasing the structure-based... |
Dishman targets India’s booming oncology marketIndia’s Dishman Pharmaceuticals is eyeing up the lucrative oncology market to further its development as one... |
MD Logistics plans Indy facility to tap local pharma boomSupply chain specialist MD Logistics is planning to set up a further distribution plant in Indiana,... |
Pharma outsourcing: people on the moveOutsourcing-Pharma.com presents its latest round-up of new appointments, employment moves and personnel news in the pharmaceutical contract... |
Previous headlines
Daewoong to sell Eurand’s cyclobenzaprine ERDrug delivery specialist Eurand is to begin supplying its... |
Pharma manufacturing products: news in briefin-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical... |
Abbott and Pfizer shed jobs as Gilead plans growthin-PharmaTechnologist.com’s periodic round-up of employment developments in the pharmaceutical manufacturing... |
Drug delivery penetrates mucus barrierResearchers claim to have developed a drug delivery system capable... |
FDA seizes drugs worth $74,000The US Food and Drug Administration (FDA) has ordered the... |
Crossing the BBB for treating Parkinson’sUS-based biotech ArmaGen Technologies has received funding from the Michael... |
Unraveling the stabilisation of proteinsEvaluating the sugars used to stabilise proteins will be faster,... |
New MRI platform makes PharmaSenseOIMBL’s PharmaSense is a versatile MRI tool that allows... |
Producing heparin without the heartacheUS researchers have developed a chemoenzymatic strategy to synthesise the... |
NJ and the shifting landscape of pharma employmentPeople employed in the pharmaceutical industry in New Jersey, USA... |
